Please login to the form below

Not currently logged in
Email:
Password:

Takeda appoints chief financial officer and corporate officer

James Kehoe takes on both roles from 15 June

Japanese pharmaceutical company Takeda has named James Kehoe as its new chief financial officer and corporate officer, based in Tokyo.

Kehoe moves to Takeda from Kraft Foods Group, where he most recently held the role of chief financial officer.

He first joined the American group in 2005 taking up the role of vice president of finance for Europe, and has since held a number of increasingly senior positions across Germany, Italy and Switzerland.

Christophe Weber, president and chief executive officer of Takeda, said: “James Kehoe's passion for transforming large organisations to achieve higher performance will hold him in good stead as he leads the global finance team to further elevate the company's business performance and help Takeda deliver its growth ambitions.”

He added: “We also believe that James's values are very much aligned with Takeda's values and that his personal style will work well with the Takeda executive team and the finance leadership team.”

6th June 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...